BIOHAVEN ($BHVN) is expected to release its quarterly earnings data on Monday, August 4th before market open, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$1.97 per share.
You can see Quiver Quantitative's $BHVN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOHAVEN Insider Trading Activity
BIOHAVEN insiders have traded $BHVN stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BHVN stock by insiders over the last 6 months:
- JOHN W CHILDS has made 4 purchases buying 32,700 shares for an estimated $996,238 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOHAVEN Hedge Fund Activity
We have seen 122 institutional investors add shares of BIOHAVEN stock to their portfolio, and 125 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INFINITUM ASSET MANAGEMENT, LLC added 7,102,000 shares (+6456.4%) to their portfolio in Q1 2025, for an estimated $170,732,080
- POINT72 ASSET MANAGEMENT, L.P. removed 922,965 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $22,188,078
- MILLENNIUM MANAGEMENT LLC added 895,457 shares (+15436.3%) to their portfolio in Q1 2025, for an estimated $21,526,786
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 783,672 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $18,839,474
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 643,946 shares (+inf%) to their portfolio in Q1 2025, for an estimated $15,480,461
- PRICE T ROWE ASSOCIATES INC /MD/ removed 589,217 shares (-17.3%) from their portfolio in Q1 2025, for an estimated $14,164,776
- FIERA CAPITAL CORP added 581,675 shares (+inf%) to their portfolio in Q1 2025, for an estimated $13,983,467
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOHAVEN Analyst Ratings
Wall Street analysts have issued reports on $BHVN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 06/18/2025
- Baird issued a "Outperform" rating on 04/28/2025
- Morgan Stanley issued a "Overweight" rating on 03/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 03/04/2025
- Deutsche Bank issued a "Buy" rating on 02/11/2025
To track analyst ratings and price targets for BIOHAVEN, check out Quiver Quantitative's $BHVN forecast page.
BIOHAVEN Price Targets
Multiple analysts have issued price targets for $BHVN recently. We have seen 6 analysts offer price targets for $BHVN in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Tessa Romero from JP Morgan set a target price of $55.0 on 06/18/2025
- Leonid Timashev from RBC Capital set a target price of $21.0 on 05/19/2025
- Brian Skorney from Baird set a target price of $57.0 on 04/28/2025
- Terence Flynn from Morgan Stanley set a target price of $63.0 on 03/07/2025
- Douglas Tsao from HC Wainwright & Co. set a target price of $54.0 on 03/04/2025
- David Hoang from Deutsche Bank set a target price of $65.0 on 02/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
